Results 101 to 110 of about 100,300 (318)
Drug-eluting coronary stents – focus on improved patient outcomes
Patient Related Outcome Measures, 2011 Zehra Jaffery, Amit Prasad, John H Lee, Christopher J WhiteDepartment of Cardiovascular Diseases, The John Ochsner Heart and Vascular Institute, Ochsner Clinic Foundation, New Orleans, LA, USAAbstract: The development of stent has been a major advance in
Jaffery Z, Prasad A, Lee JH, White CJ
doaj
Macromolecular Rapid Communications, EarlyView.Mono‐ and bivalent‐, alanine‐modified poly‐iso‐butylenes, folding into beta‐sheets, were prepared by living carbocationic polymerization and subsequent endgroup modification. These PIB‐conjugates are useful as solid polymers for the drug release of triamcinolone and nimodipine. ABSTRACT Poly‐iso‐butylene (PIB) is a well known biocompatible polymer with
Philipp S. Hilgeroth +2 more
wiley +1 more source
International Journal of Medical Sciences, 2010 Background: The efficacy of drug-eluting stents has been shown in randomized trials, but some controversy exists regarding which stent sirolimus-eluting or paclitaxel-eluting is more effective in unselected Turkish patients.
Davran Çiçek, Hasan Pekdemir, Nihat Kalay, Süleyman Binici, Hakan Altay, Haldun Müderrisoğlu
doaj
Drug eluting stents a nightmare? [PDF]
Interactive CardioVascular and Thoracic Surgery, 2007 As a contribution to the controversial discussion for the use of drug-eluting stents, the European Heart Institute of the European Academy of Sciences and Arts is emphasizing important factors: a) drug eluting stents (DES) should be used only in accordance with their on-label indications for use; b) to avoid off-label use of DES and to assure that ...
openaire +2 more sources
VIEW, EarlyView.(a) Schematic representation of the chemical cross‐linking of PVB/PCL‐TiO2‐RegIIIγ electrospun nanofibers. (b) Schematic illustration of the biomimetic dressing promoting healing in an exposed bone wound. The treatment of wounds with exposed bone has always been a difficult problem in the clinical treatment of orthopedics.
Chenhao Gong +6 more
wiley +1 more source
A novel platinum chromium everolimus-eluting stent for the treatment of coronary artery disease
Biologics: Targets & Therapy, 2013 Johan Bennett, Christophe DuboisDepartment of Cardiovascular Diseases, University Hospitals Leuven, Leuven, BelgiumAbstract: The development of coronary stents represents a major step forward in the treatment of obstructive coronary artery disease since ...
Bennett J, Dubois C
doaj
Journal of Medical Sciences, 2015 Coronary artery stent fracture (SF) occurs in drug-eluting stent (DES) era but recurrent and multiple DES fracture was rare. We report a case of recurrent and multiple-site SF and review the literature regarding the prevalence, possible mechanism, and ...
Shih-Jung Jang, Yu-Lin Ko
doaj +1 more source
Meta-analysis of randomized trials on drug-eluting stents vs. bare-metal stents in patients with acute myocardial infarction [PDF]
, 2017 Aims To compare the efficacy and safety of drug-eluting stents vs. bare-metal stents in patients with acute ST-segment elevation myocardial infarction.
Di Lorenzo, Emilio +19 more
core
Role of noncoding RNA in vascular remodelling [PDF]
, 2016 Purpose of review: Noncoding RNAs (ncRNAs), such as microRNAs (miRNAs) and long noncoding RNAs (lncRNAs) are becoming fundamentally important in the pathophysiology relating to injury-induced vascular remodelling.
Baker, Andrew H. +2 more
core +1 more source
The future of drug-eluting stents
Pharmacological Research, 2008 This review aims to provide a glimpse into the future of drug-eluting stents (DES). Since their arrival in 2002, DES have transformed the practice of interventional cardiology by drastically reducing restenosis and the need for repeat revascularization.
Kukreja, N +3 more
openaire +2 more sources